U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Detailed price information for Bay National Corp (BAYN) from The Globe and Mail including charting and trades.